VP In vitro pharm and bioanalytical
Sana Biotechnology
Cambridge, Massachusetts
Boris Gorovits is a VP, In Vitro Pharmacology and Bioanalysis, Sana Biotechnology. Boris earned Ph.D. in Enzymology from the Moscow State University, later completed postdoctoral research studies in Protein biophysics at the Medical Center, U of Texas at SA. Boris’s industry experience includes working at Regeneron, Wyeth and Pfizer, mainly focusing on bioanalytical support and immunogenicity of various modalities of biotherapeutics, support of discovery and regulated non-clinical and clinical studies. While at Pfizer, Boris co-chaired company-wide Immunogenicity Expert Working Group. Recently Boris has been involved in support of Gene and Cell therapy modalities. At Sana, Boris leads investigations focused on understanding PKPD of lentiviral vector based and CAR-T therapies, in vitro and bioanalytical studies required in support of IND applications and clinical studies. Boris is actively involved in industry conversations focusing on PK and immunogenicity assessments of various modalities, including gene therapy and CAR-T.
Disclosure information not submitted.
Monday, October 17, 2022
1:30 PM – 2:30 PM ET